Integrated Filing — IndAS

General information about company
Scrip Code	506525
NSE Symbol	KANORICHEM
MSEI Symbol	NOTLISTED
ISIN	INE138C01024
Name of company	KANORIA CHEMICALS & INDUSTRIES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	21-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	14-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	CHEMICALS
Start date and time of board meeting	21-May-2025   11:45:00
End date and time of board meeting	21-May-2025   15:45:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-02-09
Indicate Company website link for updated RPT policy of the Company	https://a.storyblok.com/f/209886/x/aa1b855e02/policy-on-related-party-transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable n

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1932900000	6783000000
	Other income	34300000	142500000
	Total income	1967200000	6925500000
2	Expenses
(a)	Cost of materials consumed	1378800000	4672900000
(b)	Purchases of stock-in-trade	26300000	189300000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	13500000	68000000
(d)	Employee benefit expense	105500000	406000000
(e)	Finance costs	43000000	160700000
(f)	Depreciation, depletion and amortisation expense	53400000	199700000
(f)	Other Expenses
1	Other Expenses	273700000	1053500000
	Total other expenses	273700000	1053500000
	Total expenses	1894200000	6750100000
3	Total profit before exceptional items and tax	73000000	175400000
4	Exceptional items	-247400000	-449900000
5	Total profit before tax	-174400000	-274500000
6	Tax expense
7	Current tax	12800000	43600000
8	Deferred tax	5900000	70700000
9	Total tax expenses	18700000	114300000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-193100000	-388800000
12	Profit (loss) from discontinued operations before tax	-2000000	25000000
13	Tax expense of discontinued operations	-400000	16000000
14	Net profit (loss) from discontinued operation after tax	-1600000	9000000
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-194700000	-379800000
17	Other comprehensive income net of taxes	-1500000	-700000
18	Total Comprehensive Income for the period	-196200000	-380500000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	218500000	218500000
	Face value of equity share capital	5	5
27	Details of debt securities
22	Reserves excluding revaluation reserve		5793700000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-4.42	-8.9
	Diluted earnings (loss) per share from continuing operations	-4.42	-8.9
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	-0.04	0.21
	Diluted earnings (loss) per share from discontinued operations	-0.04	0.21
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-4.46	-8.69
	Diluted earnings (loss) per share from continuing and discontinued operations	-4.46	-8.69
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	4227000000
	Capital work-in-progress	136900000
	Investment property	0
	Goodwill	0
	Other intangible assets	800000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	1607900000
	Trade receivables, non-current	0
	Loans, non-current	1633900000
	Other non-current financial assets	23300000
	Total non-current financial assets	3265100000
	Deferred tax assets (net)	0
	Other non-current assets	9300000
	Total non-current assets	7639100000
2	Current assets
	Inventories	590800000
	Current financial asset
	Current investments	20600000
	Trade receivables, current	1059700000
	Cash and cash equivalents	17200000
	Bank balance other than cash and cash equivalents	4800000
	Loans, current	92600000
	Other current financial assets	192100000
	Total current financial assets	1387000000
	Current tax assets (net)	108800000
	Other current assets	134400000
	Total current assets	2221000000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	9860100000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	218500000
	Other equity	5793700000
	Total equity attributable to owners of parent	6012200000
	Non controlling interest
	Total equity	6012200000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	787700000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	200000
	Total non-current financial liabilities	787900000
	Provisions, non-current	100500000
	Deferred tax liabilities (net)	583400000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1471800000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1182000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	30200000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	765000000
	Total Trade payable	795200000
	Other current financial liabilities	235900000
	Total current financial liabilities	2213100000
	Other current liabilities	120800000
	Provisions, current	42200000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	2376100000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	3847900000
	Total equity and liabilites	9860100000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassifed to Profit or Loss	-2400000	-1900000
	Total Amount of items that will not be reclassified to profit and loss	-2400000	-1900000
2	Income tax relating to items that will not be reclassified to profit or loss	-900000	-1200000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-1500000	-700000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			-274500000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			160700000
	Adjustments for decrease (increase) in inventories			-29000000
	Adjustments for decrease (increase) in trade receivables, current			-288700000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			22200000
	Adjustments for decrease (increase) in other non-current assets			200000
	Adjustments for other financial assets, non-current			-2800000
	Adjustments for other financial assets, current			-3000000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-14600000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-14700000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			199700000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			449900000
	Adjustments for provisions, current			2700000
	Adjustments for provisions, non-current			10100000
	Adjustments for other financial liabilities, current			12000000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			2400000
	Adjustments for interest income			65800000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			10700000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-48600000
	Other adjustments to reconcile profit (loss)			54700000
	Other adjustments for non-cash items			3200000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			456500000
	Net cash flows from (used in) operations			182000000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			12000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			170000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			27800000
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			6400000
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			199400000
	Purchase of property, plant and equipment			536100000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			319000000
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			2400000
	Interest received			2300000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			84100000
	Net cash flows from (used in) investing activities	-532700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			714900000
	Repayments of borrowings			174600000
	Payments of lease liabilities			0
	Dividends paid			0
	Interest paid			160700000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			379600000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			16900000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			16900000
	Cash and cash equivalents cash flow statement at beginning of period			300000
	Cash and cash equivalents cash flow statement at end of period			17200000